Effectiveness and Safety of Polydioxanone Thread-Embedding Acupuncture (TEA) and Electroacupuncture (EA) Treatment for Knee Osteoarthritis (KOA) Patients with Postoperative Pain: An Assessor-blinded, Randomized, Controlled Pilot Trial

Korea Institute of Oriental Medicine0 个研究点目标入组 36 人开始时间: 待定最近更新: 2020年12月2日

试验速览

暂无简介。

•1. Age over 40 years
•2. Diagnosed with degenerative arthritis who have passed 6 months after surgery(arthroscope, autologous chondrocyte transplantation, or autologous osteochondral transplantation)
•3. Knee pain more than VAS(Visual Analogue Scale) 40mm at screening
•4. Subjects who voluntarily decides to participate and agrees to the written agreement after having received a full explanation of the research objectives and processes
•5. Subjects who can write patient preparation data on their own or with the support of a guardian or researcher.

•1. History of arthroplasty on the knee
•2. Severe knee trauma in the last 6 months
•3. Subjects who received TEA within 6 months and EA within 2 weeks
•4. Subjects who received injection treatment such as steroids or hyaluronic acid within 3 months and prolotherapy or platelet-rich plasma(PRP) within 6 months
•5. ESR>40 mmhr, RA Factor>20IU/mL in screening clinical eamination
•6. Subjects with musculoskeletal problems that cause more pain than knee pain in other body parts
•7. Hypersensitive reaction to previous acupuncture treatment, metal allergy, severe atopy, keloid, and other skin hypersensitivities
•8. Subjects who have hemorrhagic disease, cardiovascular disease or with factors that may affect hemostasis, such as taking anti-coagulants or anti-platelets
•9. Pregnancy, nursing or diagnosed with malignant tumors
•10. Subjects who have severe diabetes or cardiovascular disease such as angina pectoris or congestive heart failure
•11. Subjects with senile dementia, severe mental or psychological disorders
•12. Subjects who has inserted pacemaker
•13. Subjects who are considered to be inappropriate for the study by the researcher

发起方